Program, Speakers and Abstract Submissions

Advancing Manufacture of Cell and Gene Therapies ​IX

Preliminary Program

Advancing Manufacture of Cell and Gene Therapies ​IX Schedule at a GlanceDownload

Plenary Speaker

Denis Claude Roy, Ph.D.
Professor, Faculty of Medicine
Université de Montréal

"Advanced therapeutics biomanufacturing in the academic-hospital setting and patient impact"

Keynote Speakers

Susan Abu-Absi, Ph.D
Chief Operating Officer
Be Bio

"Engineering the Future of CGT Manufacturing: Insights from Clinical Development and Commercialization of Advanced Therapies for Oncology and Rare Disease"

Richard D. Braatz, Ph.D.
Edwin R. Gilliland Professor of Chemical Engineering
Director, Center for Continuous mRNA Manufacturing
MIT

"Intensification of Cell and Gene Therapy Manufacturing: Modeling, Design, and Control"

Chris Stevens
Chief Operating Officer
Rocket Pharma

"From Rare Diseases to Common Conditions: Advancing Cell & Gene Therapy for the Next Era of Medicine"

Invited Speakers

Stephen Balakirsky, Georgia Institute of Technology, (United States)

Neil Blackburn, Omniabio, (United States)

Colin Cook, Xdemics Corporation, (United States)

Lindsay Fraser, Cytomos, (United Kingdom)

Alois Jungbauer, BOKU University, (Austria)

Amine A. Kamen, McGill University , (Canada)

Lise Munsie, BlueRock Therapeutics, (United States)

Ioannis Papantoniou, KU Leuven, (Belgium)

Rodney L. Rietze, Ph.D., Streamline Bio, (USA)

Antonio Roldao, iBET (Portugal)

Kris Saha, University of Wisconsin, (United States)

Luis Santos, Prime Medicine, (USA)

Margarida Serra, IBET, (Portugal)

Dan Strange, Cellular Origins, (United Kingdom)

John Tomishen, Cellares, (United States)

Tracey Turner, Bristol Myers Squibb, (United States)

Stephen Ward, Cell Therapy Catapult, (United Kingdom)

Workshop Description

Advancing Manufacture of Cell and Gene Therapies ​IX (11/15/25) [DOC]Download

Abstract Submissions

Abstract Submissions are closed. Abstracts for all presentations will be made available to conference participants prior to the start of the conference.

Click here to see the status of your abstract.

Poster Guidelines

The best posters display a succinct statement of major conclusions at the beginning, followed by supporting text in later segments and a brief summary at the end. Click here for instructions and more information.

Poster Size: 1.0 meter wide and 1.5 meters in length (Portrait style).

  • Request for Next Mailing

    Please Sign-In to your account to Request A Mailing.

  • Page Sections

  • Add Email

    To ensure receipt of ECI mailings, please add 'eci@informz.net' to your address book.

  • REGISTRATION SCAM ALERT

    Unless otherwise indicated, ECI will make your hotel reservation directly with the conference hotel after your registration is confirmed.

    Some conference participants have received fraudulent emails claiming to be from Docusign, asking them to confirm their registration. Please disregard and delete these emails. Do not click on any links contained in them.

    ECI will never contact you via telephone to make a payment, we do not use Docusign, and we do not accept PayPal. If anyone contacts you to make a reservation through a third party, please notify ECI at info@engconfintl.org.

  • Electronic Travel Authorization

    Travelers from 54 countries now are required to complete an online pre-travel check to enter the U.K.

    If your flight takes you through the UK, please read this.

  • Scam Alert!

    Unless otherwise indicated, ECI will make your hotel reservation directly with the conference hotel after your registration is confirmed. ECI will never contact you via telephone to make a payment and we do not accept PayPal. If anyone contacts you to make a reservation through a third party, please notify ECI at info@engconfintl.org.

  • TOP ^